BRG1 knockdown also increased the proliferation of GBM CSCs, which may increase chemosensitivity, because CSCs proliferate relatively slowly, and chemotherapeutic drugs target proliferating cancer cells.55, 56. This evidence concerns the gene SMARCA4 and glioblastoma.